Literature DB >> 17582443

Stochastic model of an influenza epidemic with drug resistance.

Yaji Xu1, Linda J S Allen, Alan S Perelson.   

Abstract

A continuous-time Markov chain (CTMC) model is formulated for an influenza epidemic with drug resistance. This stochastic model is based on an influenza epidemic model, expressed in terms of a system of ordinary differential equations (ODE), developed by Stilianakis, N.I., Perelson, A.S., Hayden, F.G., [1998. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. J. Inf. Dis. 177, 863-873]. Three different treatments-chemoprophylaxis, treatment after exposure but before symptoms, and treatment after symptoms appear, are considered. The basic reproduction number, R(0), is calculated for the deterministic-model under different treatment strategies. It is shown that chemoprophylaxis always reduces the basic reproduction number. In addition, numerical simulations illustrate that the basic reproduction number is generally reduced with realistic treatment rates. Comparisons are made among the different models and the different treatment strategies with respect to the number of infected individuals during an outbreak. The final size distribution is computed for the CTMC model and, in some cases, it is shown to have a bimodal distribution corresponding to two situations: when there is no outbreak and when an outbreak occurs. Given an outbreak occurs, the total number of cases for the CTMC model is in good agreement with the ODE model. The greatest number of drug resistant cases occurs if treatment is delayed or if only symptomatic individuals are treated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582443      PMCID: PMC3249396          DOI: 10.1016/j.jtbi.2007.05.009

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  29 in total

Review 1.  Perspectives on antiviral use during pandemic influenza.

Authors:  F G Hayden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Emergence of drug-resistant influenza virus: population dynamical considerations.

Authors:  Roland R Regoes; Sebastian Bonhoeffer
Journal:  Science       Date:  2006-04-21       Impact factor: 47.728

3.  Oseltamivir resistance--disabling our influenza defenses.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

4.  Antiviral resistance in influenza viruses--implications for management and pandemic response.

Authors:  Frederick G Hayden
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

5.  Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.

Authors:  Rick A Bright; Marie-jo Medina; Xiyan Xu; Gilda Perez-Oronoz; Teresa R Wallis; Xiaohong M Davis; Laura Povinelli; Nancy J Cox; Alexander I Klimov
Journal:  Lancet       Date:  2005-09-22       Impact factor: 79.321

6.  High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-01-20       Impact factor: 17.586

7.  Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

Authors:  Rick A Bright; David K Shay; Bo Shu; Nancy J Cox; Alexander I Klimov
Journal:  JAMA       Date:  2006-02-02       Impact factor: 56.272

8.  Mitigation strategies for pandemic influenza in the United States.

Authors:  Timothy C Germann; Kai Kadau; Ira M Longini; Catherine A Macken
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

9.  Potential impact of antiviral drug use during influenza pandemic.

Authors:  Raymond Gani; Helen Hughes; Douglas Fleming; Thomas Griffin; Jolyon Medlock; Steve Leach
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

10.  Strategies for mitigating an influenza pandemic.

Authors:  Neil M Ferguson; Derek A T Cummings; Christophe Fraser; James C Cajka; Philip C Cooley; Donald S Burke
Journal:  Nature       Date:  2006-04-26       Impact factor: 49.962

View more
  13 in total

1.  MEM spectral analysis for predicting influenza epidemics in Japan.

Authors:  Ayako Sumi; Ken-ichi Kamo
Journal:  Environ Health Prev Med       Date:  2011-06-07       Impact factor: 3.674

2.  Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.

Authors:  Andreas Handel; Ira M Longini; Rustom Antia
Journal:  J Theor Biol       Date:  2008-10-08       Impact factor: 2.691

3.  Modeling seasonal influenza outbreak in a closed college campus: impact of pre-season vaccination, in-season vaccination and holidays/breaks.

Authors:  Kristin L Nichol; Kate Tummers; Alanna Hoyer-Leitzel; Jennifer Marsh; Matt Moynihan; Steven McKelvey
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

4.  Towards multiscale modeling of influenza infection.

Authors:  Lisa N Murillo; Michael S Murillo; Alan S Perelson
Journal:  J Theor Biol       Date:  2013-04-19       Impact factor: 2.691

5.  Competitive analysis for stochastic influenza model with constant vaccination strategy.

Authors:  Dumitru Baleanu; Ali Raza; Muhammad Rafiq; Muhammad Shoaib Arif; Muhammad Asghar Ali
Journal:  IET Syst Biol       Date:  2019-12       Impact factor: 1.615

6.  Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.

Authors:  Robert Moss; James M McCaw; Jodie McVernon
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

7.  Time series analysis of incidence data of influenza in Japan.

Authors:  Ayako Sumi; Ken-ichi Kamo; Norio Ohtomo; Keiji Mise; Nobumichi Kobayashi
Journal:  J Epidemiol       Date:  2010-11-13       Impact factor: 3.211

8.  The timing and targeting of treatment in influenza pandemics influences the emergence of resistance in structured populations.

Authors:  Benjamin M Althouse; Oscar Patterson-Lomba; Georg M Goerg; Laurent Hébert-Dufresne
Journal:  PLoS Comput Biol       Date:  2013-02-07       Impact factor: 4.475

9.  Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.

Authors:  James M McCaw; James G Wood; Christopher T McCaw; Jodie McVernon
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

Review 10.  A modeling framework for the evolution and spread of antibiotic resistance: literature review and model categorization.

Authors:  Ian H Spicknall; Betsy Foxman; Carl F Marrs; Joseph N S Eisenberg
Journal:  Am J Epidemiol       Date:  2013-05-09       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.